繁
简
Market+ (iPhone)
Market+ (Android)
Mobile Site
US STOCKS
FUNDS
FX & CRYPTO
SH/SZ-HK
HK STOCKS
 
 
 
 
 
 
Quote Service
Market
Market
Quotes
Quotes
Analysis
Analysis
Commentary
Commentary
Warrants&CBBCs
Warrants&CBBCs
Warrants&CBBCs Overview
Warrants
CBBCs
ETF
ETF
MPF
MPF
Education
Members
Members
About Us
About Us

ETF Overview

TRACKER FUND
ISHARES A50
HSCEI ETF
CSOP A50 ETF
CAM CSI300
Last (HKD)1
Details»
Vol. 
Turn. 
Range
NAV (HKD)
Premium%
1-Month Range
2-Month Range
3-Month Range
52-Week Range
1D
1M
Advanced Chart
ETF Overview
Issuer
Expenses & Facts
Analysis
Calendar Yr Chg
Cumulative Chg
Overview (By Turn.)
Overview (By Asset)
Name/ Symbol
Underlying Asset
Last1
Chg
Chg%
Vol.
Turn.
NAV (Premium%)
Chart
Compare
TRACKER FUND
 Hang Seng Index 23.140
 HKD 		-0.380 -1.616% 811.04M 18.76B 23.512 (-1.583%)
HKD as at 2025/04/02
HSCEI ETF
 Hang Seng China Enterprises 86.040
 HKD 		-1.220 -1.398% 188.30M 16.19B 87.316 (-1.461%)
HKD as at 2025/04/01
CSOP HS TECH
 Hang Seng TECH Index 5.190
 HKD 		-0.120 -2.260% 1.01B 5.25B 5.292 (-1.931%)
HKD as at 2025/04/01
XL2CSOPHSTECH
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng TECH Index 5.515
 HKD 		-0.255 -4.419% 348.55M 1.92B 5.753 (-4.140%)
HKD as at 2025/04/01
XI2CSOPHSTECH
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng TECH Index 2.002
 HKD 		+0.090 +4.707% 819.48M 1.64B 1.925 (+3.984%)
HKD as at 2025/04/01
FI2 CSOP HSI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng Index 2.708
 HKD 		+0.088 +3.359% 231.75M 629.33M 2.614 (+3.616%)
HKD as at 2025/04/01
FL2 CSOP HSI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng Index 4.848
 HKD 		-0.162 -3.234% 67.79M 327.78M 5.032 (-3.659%)
HKD as at 2025/04/01
ISHARESHSTECH
 Hang Seng TECH Index 11.110
 HKD 		-0.290 -2.544% 24.21M 269.37M 11.335 (-1.986%)
HKD as at 2025/04/01
HSTECH ETF
 Hang Seng TECH Index 5.260
 HKD 		-0.130 -2.412% 36.74M 193.31M 5.368 (-2.008%)
HKD as at 2025/04/01
CAM CSI300
 CSI 300 42.540
 HKD 		-0.300 -0.700% 2.19M 92.76M 42.964 (-0.987%)
HKD as at 2025/04/01
FI2CSOPNASDAQ
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 NASDAQ-100 Index 6.190
 HKD 		+0.260 +4.384% 12.41M 76.76M 5.884 (+5.209%)
HKD as at 2025/04/01
A GX HSCEICC
 Hang Seng China Enterprises 10.580
 HKD 		-0.090 -0.843% 5.02M 53.06M 10.627 (-0.438%)
HKD as at 2025/04/01
SPDR GOLD TRT
 London Gold Fixing Price 2,246.000
 HKD 		+6.000 +0.268% 22.39K 50.58M N/A
ISHARES A50
 FTSE China A50 13.540
 HKD 		-0.040 -0.295% 3.53M 47.69M 13.629 (-0.654%)
HKD as at 2025/04/01
CSOP A50 ETF
 FTSE China A50 12.650
 HKD 		-0.030 -0.237% 3.16M 39.76M 12.733 (-0.650%)
HKD as at 2025/04/01
FL2CSOPGOLD
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Solactive Gold 1-Day Rolling Futures Index 15.510
 HKD 		-0.010 -0.064% 1.97M 30.83M 15.452 (+0.373%)
HKD as at 2025/04/01
FL2 CSOP HSCEI
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 Hang Seng China Enterprises 3.140
 HKD 		-0.088 -2.726% 5.51M 17.21M 3.251 (-3.399%)
HKD as at 2025/04/01
FI2 CSOP NIKKEI
-2x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Nikkei Stock Average Index 80.600
 HKD 		+5.600 +7.467% 196.08K 15.73M 75.199 (+7.182%)
HKD as at 2025/04/01
PING AN HKDIV
 CSI Hong Kong Dividend 33.340
 HKD 		-0.420 -1.244% 367.40K 12.20M 33.730 (-1.157%)
HKD as at 2025/04/01
FI CSOP HSI
-1x
Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged.
 Hang Seng Index 4.102
 HKD 		+0.064 +1.585% 2.76M 11.33M 4.030 (+1.794%)
HKD as at 2025/04/01
FL2CSOPNASDAQ
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 NASDAQ-100 Index 19.800
 HKD 		-0.980 -4.716% 569.70K 11.29M 20.948 (-5.478%)
HKD as at 2025/04/01
GX HS HIGH DIV
 Hang Seng High Dividend Yield 24.900
 HKD 		-0.180 -0.718% 408.92K 10.18M 24.934 (-0.136%)
HKD as at 2025/04/01
TRACKER FUND-R
 Hang Seng Index 21.720
 CNY 		-0.260 -1.183% 443.50K 9.64M 21.996 (-1.253%)
CNY as at 2025/04/02
ISHARESHSI
 Hang Seng Index (net total return version) 83.140
 HKD 		-1.540 -1.819% 106.97K 8.90M 84.524 (-1.637%)
HKD as at 2025/04/01
VALUEGOLD ETF
 London Gold Fixing Price 73.740
 HKD 		+0.300 +0.408% 113.80K 8.43M 73.590 (+0.204%)
HKD as at 2025/04/02
CSOP UST20
 FTSE US Treasury 20+ Years Index 72.980
 HKD 		+1.140 +1.587% 114.97K 8.36M 71.861 (+1.558%)
HKD as at 2025/04/01
CSOP HEALTHCARE
 Solactive China Healthcare Disruption Index 2.468
 HKD 		-0.042 -1.673% 3.32M 8.20M 2.507 (-1.552%)
HKD as at 2025/04/01
CAM HS TECH
 Hang Seng TECH Index 6.710
 HKD 		-0.160 -2.329% 1.20M 8.05M 6.851 (-2.058%)
HKD as at 2025/04/01
XL2CSOPCSI300
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 CSI 300 3.570
 HKD 		-0.020 -0.557% 2.21M 7.84M 3.641 (-1.958%)
HKD as at 2025/04/01
XL2 BOS CHINEXT
+2x
Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x).
 ChiNext Index (HKD)(CNH) 3.480
 HKD 		-0.120 -3.333% 2.24M 7.82M 3.614 (-3.716%)
HKD as at 2025/04/01
(1) All quotes for Hong Kong Stocks are at least 15 minutes delayed. Last Updated: 2025/04/03 14:10
 
SITEMAP
AASTOCKS.com
 
 
Members
 
About Us
Market
Quotes
 
Analysis
News & Research
 
Commentary
 
Warrants&CBBCs
 
Warrants
 
CBBCs
 
US Stocks
Forex
 
Fund
 
MPF
Email: support@aastocks.com
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司) All rights reserved.
Disclaimer
AASTOCKS.COM LIMITED (阿斯達克網絡信息有限公司), HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

The above is strictly for information purposes only and should not be considered an offer, or solicitation, to deal in any of the mentioned funds. Investment involves risk, emerging markets may have greater risk than developed markets. Subscriptions may only be made on the basis of the relevant offering documents, most recent annual financial statement and semi-annual financial statements if published thereafter. The value of investments and the income received from them (if any) may be volatile and could change substantially within a short period of time. Past performance is not a guide to future performance. The investment returns are denominated in the base currency of the fund. US dollar / HK dollar based investors are therefore exposed to fluctuations in the US dollar / HK dollar / base currency exchange rate.

BEFORE MAKING AN INVESTMENT, YOU SHOULD REFER TO THE RELEVANT OFFERING DOCUMENTS AND IN PARTICULAR TO THE INVESTMENT POLICIES AND THE RISK FACTORS. YOU SHOULD ENSURE THAT YOU FULLY UNDERSTAND THE RISKS ASSOCIATED WITH THE FUND AND SHOULD ALSO CONSIDER YOUR OWN INVESTMENT OBJECTIVE AND RISK TOLERANCE LEVEL. YOU ARE REMINDED THAT YOU ARE RESPONSIBLE FOR YOUR INVESTMENT DECISION AND SHOULD NOT INVEST UNLESS THE INTERMEDIARY WHO OFFERS OR SELLS THE FUND TO YOU HAS ADVISED THAT THE FUND IS SUITABLE FOR YOU AND HAS EXPLAINED WHY, INCLUDING HOW BUYING THE FUND WOULD BE CONSISTENT WITH YOUR INVESTMENT OBJECTIVE. IF IN DOUBT, PLEASE SEEK INDEPENDENT FINANCIAL AND PROFESSIONAL ADVICE.

The information and products contained within this website are restricted to investors within Hong Kong. There are important legal and regulatory restrictions which apply to this website. These are laid out in the Disclaimer section which you are advised to read before proceeding. By proceeding, you are representing that you have understood and accepted the restrictions set out in the Disclaimer section.

Third party websites provided by hyperlinks on this website are completely beyond the control of AASTOCKS. Accordingly, AASTOCKS accepts no responsibility for the accuracy, completeness and legality of the contents of such third party website, or for any offers, services and products contained therein.

Remarks: All HK and China Indices are real time. World indices are at least 30 – 60 minutes delayed.
 
 
 
ETF Comparison
1
2
Compare